Order Article Reprints

Wang H-W, Lai H-C, Hu T-H, Su W-P, Lu S-N, Lin C-H, Hung C-H, Chuang P-H, Wang J-H, Lee M-H, et al. On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular Carcinoma. Cancers. 2020; 12(5):1177. https://doi.org/10.3390/cancers12051177

Wang, Hung-Wei, Hsueh-Chou Lai, Tsung-Hui Hu, Wen-Pang Su, Sheng-Nan Lu, Chia-Hsin Lin, Chao-Hung Hung, Po-Heng Chuang, Jing-Houng Wang, Mei-Hsuan Lee, and et al. 2020. "On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular Carcinoma" Cancers 12, no. 5: 1177. https://doi.org/10.3390/cancers12051177

Wang, H. -W., Lai, H. -C., Hu, T. -H., Su, W. -P., Lu, S. -N., Lin, C. -H., Hung, C. -H., Chuang, P. -H., Wang, J. -H., Lee, M. -H., Chen, C. -H., & Peng, C. -Y. (2020). On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular Carcinoma. Cancers, 12(5), 1177. https://doi.org/10.3390/cancers12051177